Cancer Research Communications (CRC)

Cancer Research Communications is an open access peer-reviewed journal that encompasses the full spectrum of research on cancer. Launched in October 2021, the journal aims to accelerate the pace of discovery and stimulate innovation in cancer science and medicine by providing a venue for rapid open publication of hypotheses, methods, results, data resources, and new knowledge in all the varied disciplines of this quickly evolving field. Basic, translational, clinical, and population-level cancer research advances all fall within the scope of Cancer Research Communications. Articles report novel findings, provide support to previously published results, or present thought-provoking null results. Cancer Research Communications publishes content in nine sections that reflect its broad overall scope. Section names and descriptions follow: Molecular and Cellular Biology: Studies that investigate cancer-associated biochemical and molecular pathways and their influence on cell biology and carcinogenesis Tumor Biology: Studies that investigate the intercellular interactions and physiology governing tumor development and progression Immuno-oncology: Studies that investigate the immune system, its interactions with tumor cells, and opportunities to enhance the body's natural defenses against cancer Therapeutic Research and Development: Translational studies that investigate molecular targets, lead compounds, and experimental therapies in a preclinical setting Emerging Technologies and Data Science: Studies, methods, and large datasets that employ computational biology, high-throughput techniques, imaging, physical sciences, or engineering to investigate cancer biology Precision Medicine and Biomarkers: Clinical or translational studies aimed at optimally matching patients to treatments, including biomarkers and resistance mechanisms

Cancer Research Communications (CRC) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Cancer Biology, Translational Medicine, Clinical Research, Molecular Biology, Epidemiology , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2767-9764, Established: 2021, Impact Factor: 3.3
• Provides Crossref DOI

• Indexed in: Scopus, WoS, DOAJ, PubMed

• Not indexed in UGC CARE